Literature DB >> 27206433

[Fecal Calprotectin in Inflammatory Bowel Disease].

Jun Lee1.   

Abstract

Inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis comprise conditions characterized by chronic, relapsing immune activation and inflammation within the gastrointestinal tract. Objective estimation of intestinal inflammation is the mainstay in the diagnosis and observation of IBD, but is primarily dependent on expensive and invasive procedures such as endoscopy. Therefore, a simple, noninvasive, inexpensive, and accurate test would be extremely important in clinical practice. Fecal calprotectin is a calcium-containing protein released into the lumen that is excreted in feces during acute and chronic inflammation. It is well-researched, noninvasive, and has high sensitivity and specificity for identification of inflammation in IBD. This review will focus on the use of fecal calprotectin to help diagnose, monitor, and determine treatment in IBD.

Entities:  

Keywords:  Calprotectin; Crohn’s disease; Inflammatory bowel diseases; Ulcerative colitis

Mesh:

Substances:

Year:  2016        PMID: 27206433     DOI: 10.4166/kjg.2016.67.5.233

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  3 in total

1.  Enriched Environmental Conditions Modify the Gut Microbiome Composition and Fecal Markers of Inflammation in Parkinson's Disease.

Authors:  Yogesh Singh; Mohamed El-Hadidi; Jakob Admard; Zinah Wassouf; Julia M Schulze-Hentrich; Ursula Kohlhofer; Leticia Quintanilla-Martinez; Daniel Huson; Olaf Riess; Nicolas Casadei
Journal:  Front Neurosci       Date:  2019-10-15       Impact factor: 4.677

2.  Effects of the Administration of Probiotics on Fecal Microbiota Diversity and Composition in Healthy Individuals.

Authors:  Choong-Kyun Noh; Bong Sun Kim; Gana Hong; Jae Youn Cheong; Kwang Jae Lee
Journal:  J Neurogastroenterol Motil       Date:  2018-07-30       Impact factor: 4.924

3.  Can Giardia Infection Impair the Diagnostic Level of Fecal Calprotectin in Patients with Inflammatory Bowel Disease? A Case Report.

Authors:  Sara Mohammad Ali Gol; Hamed Mirjalali; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Iran J Parasitol       Date:  2018 Jul-Sep       Impact factor: 1.012

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.